Serglycin regulates macrophage differentiation and is associated with human atherosclerotic plaque stability

Inflammation contributes to the destabilization of atherosclerotic plaques and increases the risk of cardiovascular events such as myocardial infarction and stroke. Extracellular matrix components modulate inflammation and immune responses within the plaque microenvironment. Serglycin (SRGN), is a proteoglycan primarily expressed by immune cells that regulates inflammation, but its role in human atherosclerotic plaques remains unclear. SRGN protein levels were quantified by ELISA in carotid endarterectomy samples from patients in the Atherosclerotic Plaque Imaging Project and compared between symptomatic and asymptomatic plaques. SRGN spatial localization was evaluated by multispectral imaging and histology. Glycosylation patterns were examined by immunoprecipitation and immunoblotting. Functional effects were investigated using CRISPR-mediated SRGN knockout in THP-1 monocytes differentiated into macrophages and exposed to oxidized low-density lipoprotein (oxLDL). SRGN levels were higher in plaques from asymptomatic patients compared with plaques from symptomatic patients and localized primarily to macrophage- and lipid-rich regions. Plaque SRGN was positively associated with histological markers of plaque stability, displayed heterogeneous molecular forms and showed an inverse association with the plaque vulnerability index. In vitro, SRGN deficiency was associated with a more pro-inflammatory macrophage profile, impaired M2-like polarization, and increased lipid retention following oxLDL exposure. These findings indicate that SRGN is associated with inflammatory cell presence, lipid accumulation, and features of plaque stability in human plaques, and suggest a role for SRGN in macrophage differentiation and lipid handling in atherosclerotic lesions.

Authors

Institutions

Publication Details

Journal
American Journal of Physiology-Cell Physiology
Published
2026-11-12
DOI
https://doi.org/10.1152/ajpcell.90187.2026
Primary Topic
Atherosclerosis and Cardiovascular Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Serglycin regulates macrophage differentiation and is associated with human atherosclerotic plaque stability

Andreas Edsfeldt, Eva Bengtsson, Annelie Shami, Achilleas D. Theocharis et al.
American Journal of Physiology-Cell Physiology
Atherosclerosis and Cardiovascular Diseases
article

Serglycin regulates macrophage differentiation and is associated with human atherosclerotic plaque stability

Andreas Edsfeldt, Eva Bengtsson, Annelie Shami, Achilleas D. Theocharis, Svein O. Kolset, Erik Knutsen, Isabel Gonçalves, Kristian Pietras, Chrysostomi Gialeli, Matteo Bocci, Mihaela Nitulescu, Ana Flor Persson, Panagiotis Fountas, Jiangming Sun
article en

Abstract

Inflammation contributes to the destabilization of atherosclerotic plaques and increases the risk of cardiovascular events such as myocardial infarction and stroke. Extracellular matrix components modulate inflammation and immune responses within the plaque microenvironment. Serglycin (SRGN), is a proteoglycan primarily expressed by immune cells that regulates inflammation, but its role in human atherosclerotic plaques remains unclear. SRGN protein levels were quantified by ELISA in carotid endarterectomy samples from patients in the Atherosclerotic Plaque Imaging Project and compared between symptomatic and asymptomatic plaques. SRGN spatial localization was evaluated by multispectral imaging and histology. Glycosylation patterns were examined by immunoprecipitation and immunoblotting. Functional effects were investigated using CRISPR-mediated SRGN knockout in THP-1 monocytes differentiated into macrophages and exposed to oxidized low-density lipoprotein (oxLDL). SRGN levels were higher in plaques from asymptomatic patients compared with plaques from symptomatic patients and localized primarily to macrophage- and lipid-rich regions. Plaque SRGN was positively associated with histological markers of plaque stability, displayed heterogeneous molecular forms and showed an inverse association with the plaque vulnerability index. In vitro, SRGN deficiency was associated with a more pro-inflammatory macrophage profile, impaired M2-like polarization, and increased lipid retention following oxLDL exposure. These findings indicate that SRGN is associated with inflammatory cell presence, lipid accumulation, and features of plaque stability in human plaques, and suggest a role for SRGN in macrophage differentiation and lipid handling in atherosclerotic lesions.

American Journal of Physiology-Cell Physiology
University of Patras (GR), Malmö University (SE), University of Oslo (NO), Lund University (SE), Skåne University Hospital (SE), Wallenberg Centre for Molecular and Translational Medicine (SE), UiT The Arctic University of Norway (NO)
Atherosclerosis and Cardiovascular Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon